Abstract
Introduction
Advanced cancer patients present with a variety of physical and psychological symptoms. Fatigue is one such symptom which reduces overall quality of life and is difficult to manage. The purpose of this study was to report the presence, severity, and correlating factors of fatigue in advanced cancer patients attending an outpatient palliative radiotherapy clinic.
Materials/methods
Patients referred to the Rapid Response Radiotherapy Program between January 1999 and October 2009 completed the Edmonton Symptom Assessment System (ESAS) prior to consultation. Demographic information including age, Karnofsky Performance Status (KPS), gender, and primary cancer sites were collected. Ordinal logistic regression analysis was conducted to determine relationships between demographic information, other ESAS items, and levels of fatigue. Multivariate ordinal logistic regression analysis was used to determine the most significant predictors of fatigue. A p value of <0.05 was considered statistically significant.
Results
A total of 1,397 patients completed the ESAS prior to consultation. Median age was 68 years (range, 21–95), median KPS was 60 (range, 10–100), and slightly more males completed the ESAS (53.0%). Common primary cancers were of the lung (35.8%), breast (20.7%), and prostate (17.7%). Only 179 (12.8%) patients reported no fatigue; the majority of patients reported moderate (31.8%) or severe (34.4%) fatigue. A low KPS (p < 0.0001), being female (p = 0.0056), or being referred for bone metastases (p = 0.0185) significantly correlated with higher levels of fatigue. Patients with a genitourinary primary cancer (p = 0.0078) and/or referred for malignant spinal cord compression (p = 0.0004) reported less fatigue. All other ESAS items were significantly related to fatigue. The most significant predictors of fatigue were pain (p < 0.0001, odds ratio (OR) = 1.07), nausea (p = 0.0010, OR = 1.10), depression (p < 0.0001, OR = 1.10), drowsiness (p < 0.0001, OR = 1.33), dyspnea (p = 0.0003, OR = 1.08), and overall well-being (p < 0.0001, OR = 1.19).
Conclusion
Moderate fatigue was reported in over 66% of our advanced cancer patients prior to radiotherapy. Since radiotherapy inherently causes fatigue, proactive and multidisciplinary management is required for these patients. Similar rates of fatigue severity, in lengthier, fatigue-specific tools, suggest that the ESAS may be a good tool for screening the advanced cancer population.
Similar content being viewed by others
References
Cheung WY, Le LW, Zimmermann C (2009) Symptom clusters in patients with advanced cancers. Support Care Cancer 17(9):1223–1230
Chow E, Fan G, Hadi S et al (2008) Symptom clusters in cancer patients with brain metastases. Clin Oncol 20(1):76–82
Oi-Ling K, Man-Wah DTSE, Kam-Hung DNG (2005) Symptom distress as rated by advanced cancer patients, caregivers and physicians in the last week of life. Palliat Med 19(3):228–233
Jordhoy MS, Fayers P, Loge JH et al (2001) Quality of life in advanced cancer patients: The impact of sociodemographic and medical characteristics. Br J Cancer 85(10):1478–1485
Porock D, Kristjanson LJ, Tinnelly K et al (2000) An exercise intervention for advanced cancer patients experiencing fatigue: a pilot study. J Palliat Care 16(3):30–36
Richardson A (1998) Measuring fatigue in patients with cancer. Support Care Cancer 6(2):94–100
Biswal BM, Kumaraswamy N, Mukhtar F (2004) Prevalence of fatigue among cancer patients undergoing external radiotherapy. Southeast Asian J Trop Med Public Health 35(2):463–467
Lawrence DP, Kupelnick B, Miller K et al (2004) Evidence report on the occurrence, assessment, and treatment of fatigue in cancer patients. J Natl Cancer Inst 32:40–50
Irvine D, Vincent L, Graydon JE et al (1994) The prevalence and correlates of fatigue in patients receiving treatment with chemotherapy and radiotherapy. A comparison with the fatigue experienced by healthy individuals. Cancer Nurs 17(5):367–378
Selby D, Cascella A, Gardiner K et al (2010) A single set of numerical cutpoints to define moderate and severe symptoms for the Edmonton Symptom Assessment System. J Pain Symptom Manage 39(2):241–249
Stone P, Richards M, Hardy J (1998) Fatigue in patients with cancer. Eur J Cancer 34(11):1670–1676
Lundh Hagelin C, Wengstrom Y, Furst CJ (2009) Patterns of fatigue related to advanced disease and radiotherapy in patients with cancer-a comparative cross-sectional study of fatigue intensity and characteristics. Support Care Cancer 17(5):519–526
Brown DJ, McMillan DC, Milroy R (2005) The correlation between fatigue, physical function, the systemic inflammatory response, and psychological distress in patients with advanced lung cancer. Cancer 103(2):377–382
Stone P, Richards M, A'Hern R et al (2000) A study to investigate the prevalence, severity and correlates of fatigue among patients with cancer in comparison with a control group of volunteers without cancer. Ann Oncol 11(5):561–567
Akechi T, Kugaya A, Okamura H et al (1999) Fatigue and its associated factors in ambulatory cancer patients: a preliminary study. J Pain Symptom Manage 17(1):42–48
Pater JL, Zee B, Palmer M et al (1997) Fatigue in patients with cancer: Results with national cancer institute of canada clinical trials group studies employing the EORTC QLQ-C30. Support Care Cancer 5(5):410–413
Kroenke K, Wood DR, Mangelsdorff AD et al (1988) Chronic fatigue in primary care. Prevalence, patient characteristics, and outcome. JAMA 260(7):929–934
van Wijk CM, Kolk AM (1997) Sex differences in physical symptoms: the contribution of symptom perception theory. Soc Sci Med 45(2):231–246
Okuyama T, Tanaka K, Akechi T et al (2001) Fatigue in ambulatory patients with advanced lung cancer: prevalence, correlated factors, and screening. J Pain Symptom Manage 22(1):554–564
Blesch KS, Paice JA, Wickham R et al (1991) Correlates of fatigue in people with breast or lung cancer. Oncol Nurs Forum 18(1):81–87
Fan G, Hadi S, Chow E (2007) Symptom clusters in patients with advanced-stage cancer referred for palliative radiation therapy in an outpatient setting. Support Cancer Ther 4(3):157–162
Labori KJ, Hjermstad MJ, Wester T et al (2006) Symptom profiles and palliative care in advanced pancreatic cancer: a prospective study. Support Care Cancer 14(11):1126–1133
Motzer RJ, Michaelson MD, Redman BG et al (2006) Activity of SU11248, a multitargeted inhibitor of vascular endothelial growth factor receptor and platelet-derived growth factor receptor, in patients with metastatic renal cell carcinoma. J Clin Oncol 24(1):16–24
Loblaw DA, Perry J, Chambers A et al (2005) Systematic review of the diagnosis and management of malignant extradural spinal cord compression: the Cancer Care Ontario Practice Guidelines Initiative's Neuro-Oncology Disease Site Group. J Clin Oncol 23(9):2028–2037
Loblaw DA, Laperriere NJ (1998) Emergency treatment of malignant extradural spinal cord compression: an evidence-based guideline. J Clin Oncol 16(4):1613–1624
Smets EM, Visser MR, Willems-Groot AF et al (1998) Fatigue and radiotherapy: (A) experience in patients undergoing treatment. Br J Cancer 78(7):899–906
Bruera E, Driver L, Barnes EA et al (2003) Patient-controlled methylphenidate for the management of fatigue in patients with advanced cancer: a preliminary report. J Clin Oncol 21(23):4439–4443
Sugawara Y, Akechi T, Shima Y et al (2002) Efficacy of methylphenidate for fatigue in advanced cancer patients: a preliminary study. Palliat Med 16(3):261–263
Sarhill N, Walsh D, Nelson KA et al (2001) Methylphenidate for fatigue in advanced cancer: a prospective open-label pilot study. Am J Hosp Palliat Care 18(3):187–192
Moraska AR, Sood A, Dakhil SR et al (2010) Phase III, randomized, double-blind, placebo-controlled study of long-acting methylphenidate for cancer-related fatigue: North Central Cancer Treatment Group NCCTG-N05C7 trial. J Clin Oncol 28(23):3673–3679
Bruera E, Valero V, Driver L et al (2006) Patient-controlled methylphenidate for cancer fatigue: a double-blind, randomized, placebo-controlled trial. J Clin Oncol 24(13):2073–2078
de Boer AG, van Lanschot JJ, Stalmeier PF et al (2004) Is a single-item visual analogue scale as valid, reliable and responsive as multi-item scales in measuring quality of life? Qual Life Res 13(2):311–320
Sloan JA, Aaronson N, Cappelleri JC et al (2002) Assessing the clinical significance of single items relative to summated scores. Mayo Clin Proc 77(5):479–487
Cunny KA, Perri M (1991) Single-item vs multiple-item measures of health-related quality of life. Psychol Rep 69(1):127–130
Acknowledgments
We thank the support of the Michael and Karyn Goldstein Cancer Research Fund and Stacy Yuen for the administrative assistance.
Conflicts of interest
The authors have no conflicts of interest to disclose.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Zeng, L., Koo, K., Zhang, L. et al. Fatigue in advanced cancer patients attending an outpatient palliative radiotherapy clinic as screened by the Edmonton Symptom Assessment System. Support Care Cancer 20, 1037–1042 (2012). https://doi.org/10.1007/s00520-011-1179-8
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00520-011-1179-8